Historique
Périodique
Paying drug users to take part in research : Justice, human rights and business perspectives on the use of incentive payments
(Payer des usagers de drogues participant à une recherche : questionnements en termes de Justice, de droits de l'Homme et de business, à propos de cette pratique du paiement incitatif)
Auteur(s) :
T. SEDDON
Article en page(s) :
101-109
Refs biblio. :
21
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Note générale :
Addiction Research and Theory, 2005, 13, (2), 101-109
Résumé :
ENGLISH :
Paying research subjects as an incentive to participation is a widespread practice within health and social research. Where subjects are illegal drug users, this practice is often felt to raise particular ethical issues. This paper explores this question of paying drug users to take part in research from the perspective of three models: justice; human rights; and business. Issues discussed include whether cash payments are appropriate, payment amounts, whether incentives jeopardize informed consent and whether they offer good value-for-money for research funders. Some practical implications of the discussion are set out and four key components for good practice are proposed. Finally, in conclusion it is argued that the use of incentive payments in drugs research needs to be more fully and openly debated by researchers, research funders and other stakeholders. (Author's abstract)
ENGLISH :
Paying research subjects as an incentive to participation is a widespread practice within health and social research. Where subjects are illegal drug users, this practice is often felt to raise particular ethical issues. This paper explores this question of paying drug users to take part in research from the perspective of three models: justice; human rights; and business. Issues discussed include whether cash payments are appropriate, payment amounts, whether incentives jeopardize informed consent and whether they offer good value-for-money for research funders. Some practical implications of the discussion are set out and four key components for good practice are proposed. Finally, in conclusion it is argued that the use of incentive payments in drugs research needs to be more fully and openly debated by researchers, research funders and other stakeholders. (Author's abstract)
Affiliation :
Ctr. Criminal Justice Studies, School of Law, Univ. Leeds, Leeds LS2 9JT; T.Seddonleeds.ac.uk
Royaume-Uni. United Kingdom.
Royaume-Uni. United Kingdom.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |